Patient Responses to Incentives in Consumer-directed Health Plans: Evidence from Pharmaceuticals

Medientyp: E-Book

Titel: Patient Responses to Incentives in Consumer-directed Health Plans : Evidence from Pharmaceuticals

Beteiligte: Huckfeldt, Peter J. [Verfasser:in]; Haviland, Amelia [Sonstige Person, Familie und Körperschaft]; Mehrotra, Ateev [Sonstige Person, Familie und Körperschaft]; Sood, Neeraj [Sonstige Person, Familie und Körperschaft]; Wagner, Zachary [Sonstige Person, Familie und Körperschaft]

Körperschaft: National Bureau of Economic Research

Erschienen: Cambridge, Mass: National Bureau of Economic Research, February 2015

Umfang: 1 Online-Ressource

Sprache: Englisch

DOI: 10.3386/w20927

Identifikator:

Reproduktionsnotiz: Hardcopy version available to institutional subscribers

Entstehung:

Anmerkungen: Mode of access: World Wide Web
System requirements: Adobe [Acrobat] Reader required for PDF files

Beschreibung: Prior studies suggest that consumer-directed health plans (CDHPs) -characterized by high deductibles and health care accounts- reduce health costs, but there is concern that enrollees indiscriminately reduce use of low-value services (e.g., unnecessary emergency department use) and high-value services (e.g., preventive care). We investigate how CDHP enrollees change use of pharmaceuticals for chronic diseases. We compare two large firms where nearly all employees were switched to CDHPs to firms with conventional health insurance plans. In the first firm's CDHP, pharmaceuticals were subject to the deductible, while in the second firm pharmaceuticals were exempt. Employees in the first firm shifted the timing of drug purchases to periods with lower cost sharing and were more likely to use lower-cost drugs, but the largest effect of the CDHP was to reduce utilization. Employees in the second firm also reduced utilization, but did not shift the timing or use of low cost drugs

Zugangsstatus: Freier Zugang

Nur in Feld suchen:

Zuletzt gesuchte Begriffe: